Who invested in InxMed?
InxMed's investors include China Growth Capital.
Who invested in InxMed
Funding summaryUpdated 26 Oct 2026
$34Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $34MAug 2025
- Investors
- 1
The rounds
- Aug 2025
Founders and team
From InxMed's own website: 1 founder, 12 on the team.
Fei CaoCo-founder，President，
- Baoyuan Zhang Ph.D.Vice President，Translational Medicine
- Jie Ding Ph.D.Senior Vice President，Biometrics
- Liyuan LiuVice President，CMC
- Rangrong LiVice President，Clinical Operation
- Yi RenVice President，Human Resources
- Anfeng GuoChief Commercial Officer
- Changlan ZhuDirector，BD
- Juan WangSenior Director，Medical Liaison Sales
- Li YangSenior Director，Quality
- Libo GaoSenior Director，Drug Safety
- Shuoyun ZhouDirector，Finance
- Zhaobin ZengSenior Director，Regulatory Affairs
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about InxMed
How much has InxMed raised?
InxMed has raised $34M across 1 round since 2025.
When did InxMed last raise?
InxMed's most recent round was a Series C of $34M in Aug 2025.
What was InxMed's biggest round?
Its most recent round, $34M in Aug 2025, is also its largest on record.
Who backed InxMed first?
InxMed's first round on record, in Aug 2025, was backed by China Growth Capital.
What stage is InxMed at?
InxMed's latest named round is a Series C, in Aug 2025.
Companies like InxMed
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.